Skip to content

Treatment of kustha(Psoriasis) through Vamana Karma

The Comparative Study Of Efficacy Of Go-Ghrita & Triphaladya Ghrita For Abhyantara Snehapana Prior To Vaman Karma In The Management Of Eka-Kustha(Psoriasis)-An Open Labelled Randomized Clinical Trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/069320
Enrollment
20
Registered
2024-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Sponsors

government akhndanand ayurved college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age- Between 18- 60 years Patient willing to participate in clinical trial. Patient having clinical signs & symptoms of Ekakustha (Psoriasis). Patients having chronicity less than ten years duration. Patient who is Vamana yogya, Snehpana yogya .

Exclusion criteria

Exclusion criteria: Age less than 18 years and more than 60 years. Patient who are not willing to be included in the study. Chronicity more than ten years. Pregnant and Lactating women. Patient who is Vamana ayogya, Snehapana ayogya Patients with Hypertention. Patients with K/C/O Severe Heart Diseases, Kidney Diseases, Stroke, Liver Diseases,Uncontrolled diabetes, Pulmonary Dysfunction or COPD. Patients with history of any acute or chronic infectious diseases like TB, AIDS, Other STDs. Patients taking medications like corticosteroids, hormonal therapy, anti-depressants or any other drugs which may affect outcome of the study. Patients with alcohol addiction or drug abuse.

Design outcomes

Primary

MeasureTime frame
to improve sign and symptoms of psoariasisTimepoint: Follow up will be done for 2 week after completion of teatment.

Secondary

MeasureTime frame
efficacy of treatmentTimepoint: Follow up study will be done for the period of 2 weeks after completion of treatment.

Countries

India

Contacts

Public ContactVD Rohini Salve

GOVERNMENT AKHANDANAND AYURVED COLLEGE AND HOSPITAL

rohinirakesh2@gmail.com9313001450

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026